Chimera Biotec GmbH Bremen, Bremen, Germany

About Chimera Biotec GmbH:

Chimera biotec GmbH delivers a competitive edge to pharmaceutical and biotech companies through ultra-sensitive bioanalytical solutions designed to support every stage of drug development. With over 20 years of experience and a strong focus on regulatory-compliant ligand binding assays, the company is a trusted partner for both preclinical and clinical programs.

At the core of its technological offering is the proprietary Imperacer® (Immuno-PCR) platform, which achieves up to 1,000 times grea...ater sensitivity than conventional ELISA methods. This is complemented by a broad range of technologies including Simoa®, MSD™, and traditional ELISA, enabling tailored assay strategies for diverse analytical challenges.

Key benefits for clients:

Unmatched sensitivity: Detection in the sub-picogram range – ideal for rare targets, microsampling, and early-stage studies
Regulatory confidence: Fully validated assays under GLP/GCP standards ensure data integrity
Agile project execution: Fast assay development and flexible timelines
Platform versatility: Cross-technology expertise for PK, PD, ADA, and biomarker analysis
Collaborative approach: Scientific partnership to solve complex analytical questions
chimera biotec empowers data-driven decisions with reliable, high-quality bioanalytical results – minimizing risk and accelerating progress in therapeutic development. read more

Service Offerings:

• Assay Development
• Custom development of ligand-binding assays for challenging targets
• Transfer and optimization of existing assays to preferred platforms
• Method Validation according to GLP/GCP and FDA/EMA guidelines
• Bioanalysis & Quantitative analysis of biomarkers
• Therapeutic proteins
• Antibodies DMPK
• Feasibility studies and sensitivity benchmarking
• Selection of optimal assay platforms based on project needs
• Consulting on assay scalability and regulatory readiness

Reviews: